Investor Relations

Press Releases

Advanced Search
  • Jul 14, 2016
    -Commercialization of PortIO™ implantable vascular access device anticipated in 2017-

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that it has set a Q4 2016 timeline for FDA 510(k) submission...

  • Jun 22, 2016
    - Device designed to revolutionize treatment of Carpal Tunnel Syndrome -

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion of a pre-clinical human cadaver study,...

  • May 26, 2016

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a...

  • May 13, 2016

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company organized to conceive, develop and commercialize a diversified pipeline of innovative products, today...

  • Apr 28, 2016
    - Units to Begin Trading Today on Nasdaq Under the Ticker Symbol “PAVMU”-

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. announced today that it has completed its initial public offering of 1,060,000 units. Each unit consists of one share of common stock and one warrant. The...